Position and enforcement practice of the People's Republic of China's pharmaceutical data exclusivity protection
Na Li,1 Xiang Yu,2 Michael Pecht3 1School of Law, Ningbo University, Ningbo, People’s Republic of China; 2School of Law and Politics, Ningbo Institute of Technology, Zhejiang University, Ningbo, People’s Republic of China; 3Center for Advanced Life Cycle Engineering, University o...
Saved in:
Main Authors: | Li N (Author), Yu X (Author), Pecht M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frequency of tuberculosis among diabetic patients in the People's Republic of China
by: Wang HT, et al.
Published: (2014) -
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China
by: Lesher B, et al.
Published: (2016) -
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
by: Montgomery W, et al.
Published: (2013) -
Obesity detection rate among primary school students in the People's Republic of China: a meta-analysis
by: Jin Y, et al.
Published: (2013) -
Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review
by: Zhang R, et al.
Published: (2015)